$0.810250
-0.02-2.81%
At Close: -
$0.833300
0.022.84%
After Hours: Jul 3, 6:26 AM EDT
15 minutes delayed
Achilles Therapeutics
ACHLNASDAQ
Achilles Therapeutics (ACHL) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAchilles Therapeutics (NASDAQ:ACHL) Stock Quotes, Forecast and News Summary
Achilles Therapeutics Stock (NASDAQ: ACHL) stock price, news, charts, stock research, profile.
| Open | $0.83 |
| Close | $0.81 |
| Volume / Avg. | 33.83K / 175.75K |
| Day Range | 0.80 - 0.83 |
| 52 Wk Range | 0.74 - 1.76 |
| Market Cap | $35.59M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 40 |
| Short Interest | 0.09% |
| Days to Cover | 1 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Achilles Therapeutics Plc
Sector
Health Care
Industry
Biotechnology
Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-ce...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Achilles Therapeutics (ACHL) stock?
You can purchase shares of Achilles Therapeutics (NASDAQ:ACHL) through any online brokerage.
Who are Achilles Therapeutics (ACHL) competitors?
Other companies in Achilles Therapeutics’s space includes: Kezar Life Sciences (NASDAQ:KZR), Fortress Biotech (NASDAQ:FBIO), Estrella Immunopharma (NASDAQ:ESLA), Acurx Pharmaceuticals (NASDAQ:ACXP) and OncoCyte (NASDAQ:OCX).
What is the target price for Achilles Therapeutics (ACHL) stock?
There is no analysis for Achilles Therapeutics.
What is the forecast for Achilles Therapeutics (ACHL) stock?
Achilles Therapeutics has a consensus price target of $2.83.
Current stock price for Achilles Therapeutics (ACHL)?
The stock price for Achilles Therapeutics (NASDAQ: ACHL) is $0.8333 last updated July 3, 2024 at 6:26 AM EDT.
Does Achilles Therapeutics (ACHL) pay a dividend?
There are no upcoming dividends for Achilles Therapeutics.
When is Achilles Therapeutics (NASDAQ:ACHL) reporting earnings?
Achilles Therapeutics’s Q2 earnings are confirmed for Friday, August 2, 2024.
Is Achilles Therapeutics (ACHL) going to split?
There is no upcoming split for Achilles Therapeutics.
What sector and industry does Achilles Therapeutics (ACHL) operate in?
Achilles Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.